A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/1998
10/14/1998	EP0869816A1 Dry compositions
10/14/1998	EP0869810A1 Cyclosporin-containing soft capsule preparations
10/14/1998	EP0869808A1 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
10/14/1998	EP0869783A1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
10/14/1998	EP0869781A1 Transdermal device for the delivery of flurbiprofen
10/14/1998	EP0869776A1 Stabilised nanoparticles capable of being filtered under sterile conditions
10/14/1998	EP0869775A1 Dietary fiber delivery system
10/14/1998	EP0869774A1 Sustained release particles
10/14/1998	EP0869773A1 Archaeosomes, archaeosomes containing coenzyme q 10?, and other types of liposomes containing coenzyme q 10? as adjuvants and as delivery vehicles
10/14/1998	EP0869772A1 Bioadhesive solid dosage form
10/14/1998	EP0856312B1 Use of trospium chloride for the manufacture of a medicament for the treatment of diseases of the bladder
10/14/1998	EP0806947A4 Formulations and methods for reducing skin irritation
10/14/1998	EP0769932B1 Implanted device containing tumor cells for the treatment of cancer
10/14/1998	EP0762873B1 Stabilized biologically active compounds contained in coated microgranules which can be suspended in alimentary fluids
10/14/1998	EP0750493B1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide
10/14/1998	EP0710226B1 Novel organic products containing reactive thiol functions, one method for preparing same, and biomaterials containing said products
10/14/1998	EP0689424B1 Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
10/14/1998	EP0661968B1 Pharmaceutical composition containing carbachol and other cholinergic substances
10/14/1998	EP0656881B1 Ester and combinations of an organic nitrate and a salicylate
10/14/1998	EP0630248B1 Use of estriol for the manufacture of a transdermal therapeutic system for treating climacteric osteoporosis
10/14/1998	CN1196002A Oil-water emulsifiers
10/14/1998	CN1195994A Hormone patch
10/14/1998	CN1195993A Intranasal vaccination against gastrointestinal disease
10/14/1998	CN1195992A Method and composition for enhanced parenteral nutrition
10/14/1998	CN1195991A Preparation of preventing and/or curing trichomadesis
10/14/1998	CN1195990A PGE1-containing freeze-dried preparation and process for production thereof
10/14/1998	CN1195986A Paroxetine controlled release compositions
10/14/1998	CN1195984A Pharmaceutical formulations containing darifenacin
10/14/1998	CN1195982A Fgfr 3 as marker for mesenchymal skelftal progenitor cells
10/14/1998	CN1195981A Reverse fluorocarbon emulsion compositions for drug delivery
10/14/1998	CN1195558A Life-prolonging pill and its preparing method
10/14/1998	CN1195545A Plaster for curing cough and asthma and its producing method
10/14/1998	CN1195538A Liquid medicine for curing scald and its preparing method
10/14/1998	CN1195536A Plaster for curing hemiplegia, hypertension and contraception
10/14/1998	CN1195528A Pifukang tincture and its preparing method
10/14/1998	CN1195527A Low-salt medium molecular ethoxyl-starch liquid
10/14/1998	CN1195524A Pharmaceutical formulation
10/14/1998	CN1195523A 组合物 The composition
10/14/1998	CN1195521A Medicinal plaster with far infrared radiation function and its preparing method
10/14/1998	CN1195516A Apparatus for orienting and positioning elongate object for dispensing
10/14/1998	CA2235057A1 A cosmetic and pharmaceutical formulation containing an andiroba extract
10/13/1998	US5821349 Derivatives of cyclodextrins, their preparation and their use for incorporating hydrophobic molecules into organized surfactant systems
10/13/1998	US5821234 Administering an effective dosage of at least one antisense sequence to at least one gene expressing a cyclin or a cyclin dependent kinase which inhibits the expression of the gene
10/13/1998	US5821225 Substituted at position 22-31 of amino acid sequence of a peptide of parathyroid hormone or parathyroid hormone related peptide
10/13/1998	US5821220 Method of producing concentrated non-buffered solutions of fibronectin
10/13/1998	US5821123 Modified antibody variable domains
10/13/1998	US5821071 By introducing a nucleotide sequence encoding a syk gene; gene expression; phosphorylation of fc-gamma receptors; for combatting infections
10/13/1998	US5821056 Polynucleotide; expression vector; binding of antibody to a growth differentiation factor-9 polypeptide indicates the presence of an oocyte
10/13/1998	US5820883 Administering two separately microencapsulated active agents; first agent causes primary immune response, second agent is released in pulsating manner to potentiate response
10/13/1998	US5820882 Biocompatible microcapsules
10/13/1998	US5820881 Microspheres of diamide-dicarboxylic acids
10/13/1998	US5820880 Adding a nonionic detergent to avoid instability in the presence of alum
10/13/1998	US5820879 Method of delivering a lipid-coated condensed-phase microparticle composition
10/13/1998	US5820878 Percutaneously absorbable patch
10/13/1998	US5820877 Storage stablity; preventing leakage and evaporation
10/13/1998	US5820876 Butadiene-acrylonitrile-methyl acrylate terpolymer, paper, and aluminum sealing bag containing a nicotine patch
10/13/1998	US5820875 Applying drug formulation dissolved in a solvent mixture containing volatile ethanol and non-volatile propylene glycol monolaurate; the duration of pulse is determined by inter alia the permeability of backing to volatile solvent
10/13/1998	US5820874 Alginate fibres, method of preparation and use
10/13/1998	US5820873 Polyethylene glycol modified ceramide lipids and liposome uses thereof
10/13/1998	US5820848 Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
10/13/1998	US5820622 Analyte-controlled liquid delivery device and analyte monitor
10/13/1998	US5820587 Method and kit for preventing erectile dysfunction
10/13/1998	CA2131308C Neutral ph cleansing bar
10/08/1998	WO1998044027A1 Open pore biodegradable matrices
10/08/1998	WO1998044021A1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same
10/08/1998	WO1998044020A1 Biodegradable polymers chain-extended by phosphates, compositions, articles and methods for making and using the same
10/08/1998	WO1998043994A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules
10/08/1998	WO1998043945A1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
10/08/1998	WO1998043687A1 Discharge collection device and intravaginal drug delivery system
10/08/1998	WO1998043680A1 Method for treating solid tumors comprising injecting macroaggregated albumin to increase retention time or radioactive/therapeutic agent in tumors
10/08/1998	WO1998043675A1 Oral pharmaceutical preparations decreased in bitterness by masking
10/08/1998	WO1998043674A1 Homogenous water-free formulations containing glycerophospholipids and polar or lipophilic substances, method for the production thereof
10/08/1998	WO1998043673A1 Solvent system for enhanced penetration of pharmaceutical compounds
10/08/1998	WO1998043664A1 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
10/08/1998	WO1998043661A1 Use of substances having oxytocin activity for preparation of medicaments for wound healing
10/08/1998	WO1998043654A1 Non-aqueous colonic purgative formulations
10/08/1998	WO1998043650A1 A method and a tobramycin aerosol formulation for treatment, prevention and containment of tuberculosis
10/08/1998	WO1998043643A1 Aqueous acyclovir solution preparations
10/08/1998	WO1998043642A1 Treatment for pulmonary fibrosis
10/08/1998	WO1998043636A1 Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates
10/08/1998	WO1998043635A1 Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates
10/08/1998	WO1998043633A1 Buffered compositions containing a local anaesthetic and used as an anti-inflammatory
10/08/1998	WO1998043631A1 Mixture of primary fatty acids obtained from sugar cane wax
10/08/1998	WO1998043625A1 Use of amantadine for treatment of hepatitis c
10/08/1998	WO1998043618A2 Use of cytoskeletal inhibitors for the prevention of restenosis
10/08/1998	WO1998043616A1 Glycosylceramide-containing liposomes
10/08/1998	WO1998043615A1 Method for oral delivery of proteins
10/08/1998	WO1998043614A1 Drug preparations for treating sexual dysfunction
10/08/1998	WO1998043613A1 Ointments for treating suppurative lesions, burns and trophic ulcers at all stages, preparation and applications of same
10/08/1998	WO1998043612A1 Use of sodium channel blocker in the manufacture of a medicament for preventing optic nerve degeneration associated with glaucoma
10/08/1998	WO1998043611A1 Diffusional implantable delivery system
10/08/1998	WO1998043609A2 Chitosane microspheres
10/08/1998	WO1998043602A1 Dentifrice products and methods for remineralizing and/or mineralizing teeth
10/08/1998	WO1998043562A1 Intravaginal drug delivery system and discharge collection device
10/08/1998	WO1998043558A1 Calcium phosphate microcarriers and microspheres
10/08/1998	WO1998043555A1 Intravesical drug delivery system
10/08/1998	WO1998043554A1 Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device
10/08/1998	WO1998022097A3 Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend
10/08/1998	WO1998020027A3 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device
10/08/1998	DE19718012C1 Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe Process for the preparation perorally administered solid dosage forms with controlled drug delivery

1 ... 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 ... 2991